Speciality Medi.

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE0R0M01014
  • NSEID:
  • BSEID: 544738
INR
208.95
-10.95 (-4.98%)
BSENSE

May 22

BSE+NSE Vol: 77000

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationUpcoming Result: Speciality Medi. will declare its result soon on 28 May 2026
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

77.0 k (88.73%) Volume

Shareholding (Mar 2026)

FII

0.24%

Held by 2 FIIs

DII

0.00%

Held by 0 DIIs

Promoter

43.43%

Why is Speciality Medicines Ltd falling/rising?

22-May-2026

As of 21-May, Speciality Medicines Ltd's stock price is at 219.90, down 4.99% and has declined 26.44% over the last six days. The stock is underperforming its sector and trading below all key moving averages, indicating a bearish trend and decreased investor confidence.

As of 21-May, Speciality Medicines Ltd's stock price is falling, currently at 219.90, which reflects a decrease of 11.55 points or 4.99%. The stock has been on a downward trend, having lost value for the last six consecutive days, resulting in a total decline of 26.44% during this period. Today, the stock opened with a loss of 4.99%, reaching an intraday low of Rs 219.90.<BR><BR>In terms of performance relative to the market, the stock has underperformed its sector by 5.14%. Additionally, it is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a persistent bearish trend. Investor participation has also decreased significantly, with delivery volume dropping by 92.65% compared to the 5-day average, suggesting a lack of confidence among investors. Overall, these factors contribute to the ongoing decline in the stock's price.

View full answer

Which are the latest news on Speciality Medi.?

22-May-2026
No latest news for Speciality Medi. found.

When is the next results date for Speciality Medicines Ltd?

22-May-2026

The next results date for Speciality Medicines Ltd is 28 May 2026.

The next results date for Speciality Medicines Ltd is scheduled for 28 May 2026.

View full answer
iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Dashboard

Icon
Unrated Stock - No Analysis Available
stock-summaryMojo Parameters

Mojo Parameters

Loading Valuation Snapshot...

Stock DNA

stock-summary
Industry

Pharmaceuticals & Biotechnology

stock-summary
Market cap

INR 184 Cr (Micro Cap)

stock-summary
P/E

21.00

stock-summary
Industry P/E

35

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

0.10

stock-summary
Return on Equity

28.31%

stock-summary
Price to Book

6.35

Revenue and Profits:
Net Sales:
(Quarterly Results - )
Net Profit:
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
Icon
Company does not have enough history
Risk Adjusted Returns v/s stock-summary
Returns Beta
Icon
Beta has not been calculated since enough price history is not available
stock-summaryNews & Corporate Actions

Announcements stock-summary

Board Meeting Intimation for Meeting Of Board Of Directors Of Speciality Medicines Limited To Be Held On May 28 2026

21-May-2026 | Source : BSE

Speciality Medicines Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/05/2026 inter alia to consider and approve 1. Audited Standalone Financial Statements of the company for the financial year ended on March 31 2026. 2. To consider approve and take on record Audited Standalone Financial Results of the company for the half year and the financial Year ended on March 31 2026 as per Regulation 33 of Listing Regulations. 3. Any other matter with the permission of the Chairman.

Disclosures under Reg. 29(1) of SEBI (SAST) Regulations 2011

19-May-2026 | Source : BSE

The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Niraj Shah

Announcement under Regulation 30 (LODR)-Change in Management

28-Apr-2026 | Source : BSE

We hereby inform that the board in its meeting held on April 28 2026 has approved (1) Appointment of M/s. Hardik Jetani & Associates as secretarial Auditor of the Company for the Financial year 2025-26 and (2) Appointment of M/s. Rahul Mistri and Co. as internal Auditor of the Company for 3 financial years commencing from FY 2025-26 to FY 2027-28.

Corporate Actions stock-summary

stock-summary
BOARD MEETING

28 May 2026

stock-summary
DIVIDEND

No Dividend history available

stock-summary
SPLITS

No Splits history available

stock-summary
BONUS

No Bonus history available

stock-summary
RIGHTS

No Rights history available

stock-summaryKey Factors

Quality key factors stock-summary

Factor
Value
Sales Growth (5y)
0
EBIT Growth (5y)
0
EBIT to Interest (avg)
6.96
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
0
Sales to Capital Employed (avg)
0
Tax Ratio
0.92%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0.24%
ROCE (avg)
0
ROE (avg)
0

Valuation key factors

Factor
Value
P/E Ratio
21
Industry P/E
35
Price to Book Value
6.04
EV to EBIT
20.98
EV to EBITDA
20.52
EV to Capital Employed
5.59
EV to Sales
3.20
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
26.64%
ROE (Latest)
28.31%

Technicals key factors

Indicator
Weekly
Monthly
MACD
RSI
Bollinger Bands
KST
Dow Theory
Mildly Bearish
OBV
Mildly Bearish
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Mar 2026stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Non Institution

Pledged Promoter Holdings

None

Mutual Funds

Held by 0 Schemes

FIIs

Held by 2 FIIs (0.24%)

Promoter with highest holding

Parthkumar Babulal Goyani (21.12%)

Highest Public shareholder

Aparna Samir Thakker (7.33%)

Individual Investors Holdings

48.57%

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "alert": "No Quarterly Results declared by Speciality Medi."
  },
  {
    "link": "half-yearly",
    "btn_text": "All Half Yearly Results",
    "alert": "No Half Yearly Results declared by Speciality Medi."
  },
  {
    "link": "nine-monthly",
    "btn_text": "All Nine Monthly Results",
    "alert": "No Nine Monthly Results declared by Speciality Medi."
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Standalone) - Mar'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "Not Applicable: The company has declared_date for only one period",
        "dir": 0
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "Not Applicable: The company has declared_date for only one period",
        "dir": 0
      }
    ],
    "table": {
      "header": [
        "Mar'25",
        "Mar'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "58.27",
          "val2": "27.52",
          "chgp": "111.74%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "9.09",
          "val2": "5.25",
          "chgp": "73.14%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.47",
          "val2": "0.60",
          "chgp": "-21.67%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "8.61",
          "val2": "2.93",
          "chgp": "193.86%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "15.60%",
          "val2": "19.08%",
          "chgp": "-3.48%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]

Annual Results Snapshot (Standalone) - Mar'25stock-summary

Mar'25
Mar'24
Change(%)
Net Sales
58.27
27.52
111.74%
Operating Profit (PBDIT) excl Other Income
9.09
5.25
73.14%
Interest
0.47
0.60
-21.67%
Exceptional Items
0.00
0.00
Standalone Net Profit
8.61
2.93
193.86%
Operating Profit Margin (Excl OI)
15.60%
19.08%
-3.48%
Values in Rs Cr.
Net Sales

Not Applicable: The company has declared_date for only one period

Standalone Net Profit

Not Applicable: The company has declared_date for only one period

stock-summaryCompany CV
About Speciality Medicines Ltd stock-summary
stock-summary
Speciality Medicines Ltd
Micro Cap
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates stock-summary
Icon
No Company Details Available